目的 研究CT增强扫描与MRI在 诊断原发性肝癌患者中临床价值。方 法 选取我院2013年6月至2016年12月61 例拟诊为原发性肝癌患者为研究对象， 所有患者均行CT增强扫描与MRI检查，并 接受手术治疗。计算CT增强扫描与MRI检 查诊断原发性肝癌的灵敏度、特异度、 阳性预测值、阴性预测值、准确性。结 果 CT增强扫描诊断灵敏度、特异度、准 确率分别为88.2%、70.0%、85.3%。MRI 检查诊断灵敏度、特异度、准确率分别 为96.1%、80.0%、93.4%。CT增强扫描与 MRI检查的灵敏度、特异度、阳性预测 值、阴性预测值、准确率比较差异无统 计学意义(P＞0.05)。结论 CT增强扫描与 MRI检查在诊断原发性肝癌方面均具有较 高准确性，可以充分考量患者病情与经 济情况，选取适当检查方法。

Objective To study the clinical value of CT enhanced scan and MRI in the diagnosis of primary liver cancer. Methods A total of 61 patients with primary liver cancer admitted to our hospital between June 2013 and December 2016 were enrolled in the study. All patients were examined by CT enhanced scan and MRI and all received operation. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of CT enhanced scan and MRI in the diagnosis of primary liver cancer were calculated. Results The diagnostic sensitivity, specificity and accuracy of CT were 88.2%, 70.0% and 85.3%, respectively while of MRI were 96.1%, 80.0% and 93.4%, respectively. There was no significant difference in the sensitivity, specificity, positive predictive value, negative predictive value and accuracy between CT enhanced scan and MRI (P>0.05). Conclusion The accuracy rates of both CT enhanced scan and MRI are high in the diagnosis of primary liver cancer. The appropriate examination methodcanbe chosen according to the patient's condition and economic situation.